| Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging L Martincich, F Montemurro, G De Rosa, V Marra, R Ponzone, S Cirillo, ... Breast cancer research and treatment 83, 67-76, 2004 | 301 | 2004 |
| Correlations between diffusion-weighted imaging and breast cancer biomarkers L Martincich, V Deantoni, I Bertotto, S Redana, F Kubatzki, I Sarotto, ... European radiology 22, 1519-1528, 2012 | 276 | 2012 |
| Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer H Yu, M Giai, EP Diamandis, D Katsaros, DJA Sutherland, MA Levesque, ... Cancer research 55 (10), 2104-2110, 1995 | 271 | 1995 |
| Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survival C Sfiligoi, A de Luca, I Cascone, V Sorbello, L Fuso, R Ponzone, N Biglia, ... International journal of cancer 103 (4), 466-474, 2003 | 267 | 2003 |
| Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight N Biglia, G Moggio, E Peano, P Sgandurra, R Ponzone, RE Nappi, ... The journal of sexual medicine 7 (5), 1891-1900, 2010 | 198 | 2010 |
| Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue H Yu, EP Diamandis, M Levesque, M Giai, R Roagna, R Ponzone, ... Breast cancer research and treatment 40, 171-178, 1996 | 177 | 1996 |
| Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study N Biglia, E Peano, P Sgandurra, G Moggio, E Panuccio, M Migliardi, ... Gynecological Endocrinology 26 (6), 404-412, 2010 | 171 | 2010 |
| miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1 D Cimino, C De Pittà, F Orso, M Zampini, S Casara, E Penna, E Quaglino, ... The FASEB Journal 27 (3), 1223-1235, 2013 | 160 | 2013 |
| Serum total and free prostate-specific antigen for breast cancer diagnosis in women MH Black, M Giai, R Ponzone, P Sismondi, H Yu, EP Diamandis Clinical cancer research 6 (2), 467-473, 2000 | 148 | 2000 |
| Menopause after breast cancer: a survey on breast cancer survivors N Biglia, M Cozzarella, F Cacciari, R Ponzone, R Roagna, F Maggiorotto, ... Maturitas 45 (1), 29-38, 2003 | 147 | 2003 |
| Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues D Cimino, L Fuso, C Sfiligoi, N Biglia, R Ponzone, F Maggiorotto, G Russo, ... International journal of cancer 123 (6), 1327-1338, 2008 | 139 | 2008 |
| Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer GM Yousef, A Scorilas, LG Kyriakopoulou, L Rendl, M Diamandis, ... Clinical chemistry 48 (8), 1241-1250, 2002 | 128 | 2002 |
| Vaginal oestrogen therapy after breast cancer: is it safe? R Ponzone, N Biglia, ME Jacomuzzi, F Maggiorotto, L Mariani, ... European Journal of Cancer 41 (17), 2673-2681, 2005 | 122 | 2005 |
| Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality PC Gøtzsche Cancer 94 (2), 578-578, 2002 | 118 | 2002 |
| Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer. M Giai, R Roagna, R Ponzone, M De Bortoli, C Dati, P Sismondi Anticancer research 14 (3B), 1441-1450, 1994 | 112 | 1994 |
| Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) N Biglia, F Maggiorotto, V Liberale, VE Bounous, LG Sgro, S Pecchio, ... European Journal of Surgical Oncology (EJSO) 39 (5), 455-460, 2013 | 105 | 2013 |
| Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer V Rossi, I Sarotto, F Maggiorotto, P Berchialla, F Kubatzki, N Tomasi, ... The Oncologist 17 (11), 1418-1425, 2012 | 104 | 2012 |
| Neoadjuvant or adjuvant chemotherapy in early breast cancer? F Montemurro, I Nuzzolese, R Ponzone Expert opinion on pharmacotherapy 21 (9), 1071-1082, 2020 | 97 | 2020 |
| Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer A Chang, GM Yousef, A Scorilas, L Grass, P Sismondi, R Ponzone, ... British journal of cancer 86 (9), 1457-1464, 2002 | 92 | 2002 |
| Prostate-specific antigen in serum of women with breast cancer M Giai, H Yu, R Roagna, R Ponzone, D Katsaros, MA Levesque, ... British journal of cancer 72 (3), 728-731, 1995 | 90 | 1995 |
